A shortage listing ends. 24 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
The archive — 2025
Page 53 of 68 of this archive, newest first.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.
What a 34% rise in coupling-reagent prices does to a 30 mg vial
Follow the resin, not the catalogue.
Do you need the top of the ladder?
The dose-response curve in this class flattens near its top. That has direct consequences for whether the final rung is worth climbing.
When a symptom is information and when it is noise
The practice is near-universal, clinically sensible, and supported by observational data rather than randomised comparison. We say which is which.
What the new Germany guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
STEP 3 extension data: what happens after the trial stops
A design note rather than a result: what the comparator was, and what that permits you to conclude.
New Zealand caps exenatide prescribing to 16 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
What twenty companies say about storage, and what they have measured
A retest date says that material should be re-examined before use. An expiry date says it should not be used. The trade uses the second word for the first concept.
Storage after reconstitution, and the evidence behind the numbers
Sharps disposal is a legal obligation in most jurisdictions and a safety obligation everywhere. Household waste is not a route.
A supplier suspends shipping to Ireland after 15 consecutive customs detentions
The route did not close because of a rule about peptides.
STEP 3 misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
Canada health authority warns on falsified liraglutide pens
Reported from the analysis, not from a warning notice.
The consolidator trading as Meridian Freight Partners closes after 5 years
A proper account of an operation that existed, and of what closing it cost.
Why your laboratory interval differs from the one in the textbook
The arithmetic of the reference change value, worked for the analytes that matter here.
How a claim degrades between the bench and the listing
The Journal does not treat a badge as evidence and states so wherever it reports one.
What a 26% rise in coupling-reagent prices does to a 15 mg vial
Follow the resin, not the catalogue.
A supplier suspends shipping to New Zealand after 6 consecutive customs detentions
The route did not close because of a rule about peptides.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
Falling ferritin is not always falling iron
Three different explanations for the same abnormal number, and how to tell them apart.
Why the bone question is harder than the muscle question
Density is a proxy for strength and an imperfect one, particularly when soft-tissue thickness over the measurement site is changing.
The sample is not the batch
Chain of custody, in a regulated setting, begins at sampling. Here it begins when the package arrives.
What the new India guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
From the floor in Guangzhou: 7 posters, one theme
Reported from the sessions, and from the two hours afterwards.
Holograms, QR codes and other things that are not verification
Reported from the analysis, not from a warning notice.
Six words a verification badge would need to mean anything
Every step between the laboratory report and the product page removes information, and the badge is the last step.
A shortage listing ends. 9 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
Independent analysis puts a WWB semaglutide lot at 96.9%, against 93.3% on the certificate
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.